Hardman Research

Hardman & Co

Alliance Pharma Plc Managing a period of change

Alliance Pharma Plc (LON:APH) has adopted a buy-and-build strategy to evolve through a series of 28 acquisitions into a profitable, cash generative, specialty pharma business. The acquisition of part of

Hardman & Co

Burford Capital Retail bond issue oversubscribed

Burford Capital Limited (LON:BUR) raised £100 million in its second bond issue on 19 April. Burford’s retail bond issue was oversubscribed and the Company raised £10 million more than its

Hardman & Co

Real Good Food Plc Profits to rise to 30% FY17

We reinstate FY17 Real Good Food Plc (LON:RGF) estimates, having suspended forecasts in February post the Real Good Food trading update on 1st of that month. Food manufacturing is a robust

Hardman & Co

Allergy Therapeutics Plc Responding to investment

Allergy Therapeutics Plc (LON:AGY) is a long-established specialist in the prevention, diagnosis and treatment of allergies. The first half of fiscal 2016 has been fueled by the progress made in